Micrus Endovascular Corporation (MEND) Receives Approval to Market DeltaPaq and DeltaPlush Microcoils in Japan
6/17/2010 8:52:14 AM
SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (NASDAQ:MEND) today announced receipt of Shonin approval from the Ministry of Health, Labour and Welfare to market in Japan its novel bare platinum and Cerecyte® DeltaPaq™ filling and DeltaPlush™ finishing microcoils for the treatment of cerebral aneurysms and treatments in the peripheral vasculature. DeltaPaq and DeltaPlush microcoils feature Micrus Endovascular’s Delta Wind™ technology, which is designed to achieve greater intra-aneurysmal packing density than conventional microcoils. Sales of DeltaPaq and DeltaPlush microcoils in Japan will be managed by Goodman Co., Ltd., Micrus Endovascular’s exclusive distributor in the Japanese market.
comments powered by